What's new

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Feb 12, 2025 - 10:30
 0
Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Pemetrexed Fresenius K...

Next Article

Regulating the Magnetic Domain of Nickle for Enhanced CO2 Electrochemical Reduct...

Related Posts

Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withdrawn

Orphan designation: Octreotide acetate Treatment of acr...

Mar 21, 2025  0

Veterinary medicines European public assessment report (EPAR): Omeprazole TriviumVet, omeprazole, Status: Authorised

Veterinary medicines European public assessment report ...

Apr 15, 2025  0

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 16, 2025  0